<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000589421"><TermName>Tazorac</TermName><TermPronunciation>(TAZ-oh-rak)</TermPronunciation><TermDefinition><DefinitionText>A drug used on the skin to treat several skin conditions. It is also being studied in the treatment of basal cell skin cancer and basal cell nevus syndrome. Tazorac is related to vitamin A and is made in the laboratory. It turns on a gene that may help stop the growth of skin cancer cells. Tazorac is a type of synthetic retinoid. Also called Avage and tazarotene.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000704879" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Tazorac&quot;" language="en" id="_3"/><MediaLink ref="CDR0000704878" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Tazorac&quot;" language="es" id="_4"/><SpanishTermName>Tazorac</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se aplica sobre la piel para tratar varias afecciones cutáneas. Asimismo, está en estudio para el tratamiento de cáncer de la piel de células basales y el síndrome de nevo de células basales. Tazorac se relaciona con la vitamina A y se produce en el laboratorio. Estimula un gen que puede ayudar a detener el crecimiento de las células cancerosas de la piel. Tazorac es un tipo de retinoide sintético. También se llama Avage y tazaroteno.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-03-10</DateFirstPublished></GlossaryTerm>
